Definition: The [test] Is Intended For Use With Specimens From Patients For Whom There Is Clinical Suspicion Of Tuberculosis (TB) And Who Have Received No Antituberculosis Therapy, Or Less Than 3 Days Of Therapy. This [test] Is Intended As An Aid In The Diagnosi
Device Type ID | 3560 |
Device Name | System, Nucleic Acid-based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen |
Physical State | In Vitro Diagnostic |
Technical Method | Nested Real-time PCR. The [test] Must Be Used In Conjunction With Mycobacterial Culture To Address The Risk Of False Negative Results And To Recover The Organisms For Further Characterization And Drug Susceptibility Testing. The [test] Should Only Be |
Target Area | Sputum |
Regulation Description | Nucleic Acid-based In Vitro Diagnostic Devices For The Detection Of Mycobacterium Tuberculosis Complex (MTB-complex) And The Genetic Mutations Associated With MTB-complex Antibiotic Resistance In Respiratory Specimens. |
Regulation Medical Specialty | Microbiology |
Review Panel | Microbiology |
Premarket Review | Office Of In Vitro Diagnostics And Radiological Health (OIR) |
Submission Type | 510(k) |
CFR Regulation Number | 866.3373 [🔎] |
FDA Device Classification | Class 2 Medical Device |
Product Code | PEU |
GMP Exempt | No |
Summary MR | Eligible |
Implanted Device | No |
Life Support Device | No |
Third Party Review | Not Third Party Eligible |
Device Type ID | 3560 |
Device | System, Nucleic Acid-based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen |
Product Code | PEU |
FDA Device Classification | Class 2 Medical Device |
Regulation Description | Nucleic Acid-based In Vitro Diagnostic Devices For The Detection Of Mycobacterium Tuberculosis Complex (MTB-complex) And The Genetic Mutations Associated With MTB-complex Antibiotic Resistance In Respiratory Specimens. |
CFR Regulation Number | 866.3373 [🔎] |
Premarket Reviews | ||
---|---|---|
Manufacturer | Decision | |
CEPHEID | ||
SUBSTANTIALLY EQUIVALENT | 1 |